Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptamer Group Share News (APTA)

Share Price Information for Aptamer Group (APTA)

Share Price is delayed by 15 minutes
Get Live Data
0.525    0.025 (4.76%)
Bid:
0.50
Ask:
0.55
Spread: 0.05 (10.00%)
Market Cap: £19.00m
APTA Live PriceLast checked at - London Stock Exchange

Intraday Aptamer Group Share Chart

Aptamer Group News

Aptamer applies for patent over binder sequences developed with Unilever
8 Apr 2024

Aptamer applies for patent over binder sequences developed with Unilever

(Sharecast News) - Aptamer Group announced the submission of a patent application safeguarding newly-crafted Optimer binder sequences on Monday.

EARNINGS AND TRADING: Arbuthnot ups payout as profit more than doubles
28 Mar 2024

EARNINGS AND TRADING: Arbuthnot ups payout as profit more than doubles

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

Aptamer shares jump on successful Unilever contract progression
11 Mar 2024

Aptamer shares jump on successful Unilever contract progression

(Alliance News) - Aptamer Group PLC shares rose on Monday, after it noted progression on its contract with Unilever PLC.

Aptamer says new Optimer+ delivers improved results
27 Feb 2024

Aptamer says new Optimer+ delivers improved results

(Alliance News) - Aptamer Group PLC on Tuesday said its new Optimer+ platform delivers improved results compared to standard binders.

Aptamer and Neuro-Bio begin Alzheimer's test development second phase
22 Feb 2024

Aptamer and Neuro-Bio begin Alzheimer's test development second phase

(Alliance News) - Aptamer Group PLC on Thursday said it has entered the second phase of developing Optimer binders for the early diagnosis of Alzheime...

Aptamer shares plunge as half-year revenue to fall by 70%
5 Feb 2024

Aptamer shares plunge as half-year revenue to fall by 70%

(Alliance News) - Aptamer Group PLC on Monday said it will miss its half-year revenue expectations as a result of weak customer demand.

Aptamer reports decent technical, commercial progress
15 Dec 2023

Aptamer reports decent technical, commercial progress

(Sharecast News) - Aptamer Group reported solid progress on both the technical and commercial fronts on Friday as it held its annual general meeting.

Aptamer inks £0.55m agreement with biotech firm
14 Dec 2023

Aptamer inks £0.55m agreement with biotech firm

(Sharecast News) - Aptamer Group announced a significant agreement with a biotechnology company on Thursday, focussed on genetic medicines.